Northwest Biotherapeutics (NWBO) EBIT Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) EBIT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Northwest Biotherapeutics | 278.23 Mn | 277.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154,441.00 |
| Mar 31, 2026 | 598,181.00 |
| Dec 31, 2025 | 263,441.00 |
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 36.55 Mn |
| Mar 31, 2025 | -324,206.00 |
| Dec 31, 2024 | -725,772.00 |
| Sep 30, 2024 | -303,548.00 |
| Jun 30, 2024 | -228,197.00 |
| Mar 31, 2024 | -325,281.00 |
| Dec 31, 2023 | -406,611.00 |
| Sep 30, 2023 | -134,800.00 |
| Jun 30, 2023 | 56,686.00 |
| Mar 31, 2023 | 520,561.00 |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 196,777.00 |
| Jun 30, 2022 | 769,605.00 |
| Mar 31, 2022 | 1.45 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | 658,634.00 |